Adagio Medical Holdings Net Long-Term Debt 2020-2024 | ADGM
Adagio Medical Holdings net long-term debt from 2020 to 2024. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
| Adagio Medical Holdings Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $16 |
| 2023 | $22 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $N/A |
| 2019 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.019B | $0.001B |
| Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif. | |||